NO20043860L - Depotlegemiddel, baerermaterialer for depotlegemidler og fremgangsmate for fremstilling av slike - Google Patents

Depotlegemiddel, baerermaterialer for depotlegemidler og fremgangsmate for fremstilling av slike

Info

Publication number
NO20043860L
NO20043860L NO20043860A NO20043860A NO20043860L NO 20043860 L NO20043860 L NO 20043860L NO 20043860 A NO20043860 A NO 20043860A NO 20043860 A NO20043860 A NO 20043860A NO 20043860 L NO20043860 L NO 20043860L
Authority
NO
Norway
Prior art keywords
carrier
custodian
carrier materials
agent
manufacture
Prior art date
Application number
NO20043860A
Other languages
English (en)
Norwegian (no)
Inventor
Gabriele Reich
Berthold Kohler
Original Assignee
Stoess & Co Gelatine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stoess & Co Gelatine filed Critical Stoess & Co Gelatine
Publication of NO20043860L publication Critical patent/NO20043860L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/593Polyesters, e.g. PLGA or polylactide-co-glycolide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1658Proteins, e.g. albumin, gelatin
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G81/00Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1641Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Detergent Compositions (AREA)
  • Biological Treatment Of Waste Water (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Materials For Medical Uses (AREA)
NO20043860A 2002-02-16 2004-09-15 Depotlegemiddel, baerermaterialer for depotlegemidler og fremgangsmate for fremstilling av slike NO20043860L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10206517A DE10206517A1 (de) 2002-02-16 2002-02-16 Depotarzneimittel, Trägermaterialien für Depotarzneimittel und Verfahren zu deren Herstellung
PCT/EP2003/000725 WO2003068192A1 (de) 2002-02-16 2003-01-24 Depotarzneimittel, trägermaterialien für depotarzneimittel und verfahren zu deren herstellung

Publications (1)

Publication Number Publication Date
NO20043860L true NO20043860L (no) 2004-09-15

Family

ID=27674694

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20043860A NO20043860L (no) 2002-02-16 2004-09-15 Depotlegemiddel, baerermaterialer for depotlegemidler og fremgangsmate for fremstilling av slike

Country Status (17)

Country Link
EP (1) EP1474110B1 (da)
AT (1) ATE369123T1 (da)
AU (1) AU2003210181A1 (da)
BR (1) BR0307675A (da)
DE (2) DE10206517A1 (da)
DK (1) DK1474110T3 (da)
EA (1) EA006988B1 (da)
ES (1) ES2289304T3 (da)
HU (1) HUP0500119A3 (da)
IL (2) IL162868A0 (da)
MX (1) MXPA04006982A (da)
NO (1) NO20043860L (da)
NZ (1) NZ533103A (da)
PL (1) PL371785A1 (da)
PT (1) PT1474110E (da)
WO (1) WO2003068192A1 (da)
ZA (1) ZA200403979B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20060682A1 (it) * 2006-12-19 2008-06-20 Sicit Chemitech S P A Nuovi derivati polimerici biodegradabili
DE102007011606A1 (de) 2007-03-02 2008-09-04 Carl Freudenberg Kg Faser-Wirrgelege

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2046830C (en) * 1990-07-19 1999-12-14 Patrick P. Deluca Drug delivery system involving inter-action between protein or polypeptide and hydrophobic biodegradable polymer
GB9211268D0 (en) * 1992-05-28 1992-07-15 Ici Plc Salts of basic peptides with carboxyterminated polyesters
US6346274B1 (en) * 1995-03-10 2002-02-12 Roche Diagnostics Gmbh Polypeptide-containing pharmaceutical forms of administration in the form of microparticles and method for the preparation thereof
DE19813174A1 (de) * 1998-03-25 1999-05-27 Schering Ag Mikropartikel aus Polymeren und mindestens einer gerüstbildenden Komponente und ihre Herstellung und Verwendung in der Ultraschalldiagnostik und zur ultraschallinduzierten Wirkstofffreisetzung
EP1171006B1 (en) * 1999-04-16 2006-03-29 Wm. MARSH RICE UNIVERSITY Functionalized poly(propylene fumarate) and poly(propylene fumarate-co-ethylene glycol)

Also Published As

Publication number Publication date
EP1474110B1 (de) 2007-08-08
ATE369123T1 (de) 2007-08-15
EP1474110A1 (de) 2004-11-10
ES2289304T3 (es) 2008-02-01
WO2003068192A1 (de) 2003-08-21
EA200401012A1 (ru) 2005-04-28
BR0307675A (pt) 2005-01-11
IL162868A (en) 2008-03-20
PT1474110E (pt) 2007-10-01
NZ533103A (en) 2007-04-27
AU2003210181A1 (en) 2003-09-04
HUP0500119A2 (hu) 2005-07-28
DE10206517A1 (de) 2003-09-04
EA006988B1 (ru) 2006-06-30
ZA200403979B (en) 2004-11-29
IL162868A0 (en) 2005-11-20
HUP0500119A3 (en) 2008-04-28
PL371785A1 (en) 2005-06-27
DK1474110T3 (da) 2007-12-10
DE50307874D1 (de) 2007-09-20
MXPA04006982A (es) 2004-11-10

Similar Documents

Publication Publication Date Title
DE602005003343D1 (de) Arzneiimittel mit verdecktem geschmack in aufbrechenden multipartikeln
ATE514749T1 (de) Harzzusammensetzung zur entladung statischer elektrizität und ihre herstellungsverfahren
IL173078A0 (en) Multiparticle pharmaceutical dosage form containing a mucoadhesively formulated peptide or protein active substances method for producing said pharmaceutical dosage form
ATE554804T1 (de) Verfahren zur herstellung von beschichteten medizinischen vorrichtungen
GB2409662A (en) Method of production of composite materials
DE69602517D1 (de) Biologisch abbaubare und kompostierbare polymere hergestellt aus konjugierten dienen wie isopren oder 2,3-dimethyl-1,3-butadien
ZA200801639B (en) Cleansing compositions containing film
ATE362012T1 (de) Hydroxy-phenoxyetherpolymere in der papierherstellung
ATE427981T1 (de) Thermoplastische zusammensetzung, herstellungsverfahren und daraus gebildete gegenstande
MXPA03003473A (es) Metodos para producir compuestos de oxazolidinona.
WO2004100857A3 (en) Highly plastic granules for making fast melting tablets
NZ594105A (en) Novel macrocyclic inhibitors of hepatitis c virus replication
BRPI0412798A (pt) uso de uma combinação de um antagonista de fator de crescimento endotelial vascular e um agente antiproliferativo, método de inibir ou reduzir o crescimento de tumor, composição farmacêutica, uso de uma combinação de um antagonista de vegf e um agente quimioterapêutico, e, artigo de fabricação
MY134275A (en) Multi-layer film and medicine container using the same
ATE330943T1 (de) Herstellungsverfahren von huperzine a und deren analogen und verbindungen nützlich dazu
ATE326985T1 (de) Lyophilisierte pharmazeutische zusammensetzung von propofol
ATE441359T1 (de) Stethoskop
NO20043860L (no) Depotlegemiddel, baerermaterialer for depotlegemidler og fremgangsmate for fremstilling av slike
HK1060716A1 (en) Polycarbonate composite material which can be thermoplastically shaped, methods for the production thereof, use of the same and a flame-proof polycarbonate moulded part
ES2065688T3 (es) Contenedor y procedimiento para su fabricacion.
TW200613486A (en) Glass fiber binder composition and mat made of glass fiber
ES2165970T3 (es) Forma farmaceutica solida con principio activo distribuido en un material polimerico.
WO2005009711A3 (fr) Implant de chirurgie plastique a regularite amelioree et procede de fabrication correspondant
BR0010499A (pt) Agentes endoparasiticidas
ATE411051T1 (de) Polypeptid, dessen konjugat doxorubicin enthält, und auf diesem basierende pharmazeutische zusammensetzung

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application